Overview

Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)

Status:
Not yet recruiting

Trial end date:
2026-11-19

Target enrollment:

Participant gender:

Summary

This is an investigator-initiated, single-arm, exploratory clinical study.The study population consisted of non-operative Locally Advanced Esophageal Cancer . The purpose of this study was to evaluate the efficacy and safety of Concurrent Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Patients With Locally-advanced Esophageal Squamous Cell Cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Shanghai Chest Hospital

Treatments:

Immune Checkpoint Inhibitors